Company / Total Assets
LENZ Therapeutics, Inc. Total Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$305.9M
FY2025
5-year range
$70.4M / $402.0M
FY2021-FY2025
Trend
+42.1%
vs FY2024
Sector context
#181 of 214
Health Care
What the data says
LENZ Therapeutics, Inc.'s total assets of $306M is lower than 85% of companies in the Health Care sector (FY2025). Improved from $70M to $306M over the past 2 years.
Based on SEC 10-K filings.
$306M in FY2025 with a 5-year CAGR of +68.4%.
Improved from $70M to $306M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -1.7%
- 5-Year CAGR
- +68.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 214This company $305.9M Sector average $7.5B
▼
-95.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +68.4%, indicating consistent growth.
- In FY2025, total assets increased 42.1% year-over-year.
- Ranks #181 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.71 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $305.9M | +42.1% |
| FY2024 | $215.3M | +205.9% |
| FY2023 | $70.4M | -78.1% |
| FY2022 | $321.9M | -19.9% |
| FY2021 | $402.0M | +1681.5% |
| FY2020 | $22.6M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026